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Abstract
Translesion synthesis (TLS) is a mutagenic branch of cellular DNA damage tolerance that enables 
bypass replication over DNA lesions carried out by specialized low-fidelity DNA polymerases. 
The replicative bypass of most types of DNA damage is performed in a two-step process of Rev1/
Polζ-dependent TLS. In the first step, a Y-family TLS enzyme, typically Polη, Polι or Polκ, inserts 
a nucleotide across DNA lesion. In the second step, a four-subunit B-family DNA polymerase Polζ 
(Rev3/Rev7/PolD2/PolD3 complex) extends the distorted DNA primer-template. The coordinated 
action of error-prone TLS enzymes is regulated through their interactions with the two scaffold 
proteins, the sliding clamp PCNA and the TLS polymerase Rev1. Rev1 interactions with all other 
TLS enzymes are mediated by its C-terminal domain (Rev1-CT), which can simultaneously bind 
the Rev7 subunit of Polζ and Rev1-interacting regions (RIRs) from Polη, Polι or Polκ. In this 
work, we identified a previously unknown RIR motif in the C-terminal part of PolD3 subunit of 
Polζ whose interaction with the Rev1-CT is among the tightest mediated by RIR motifs. Three-
dimensional structure of the Rev1-CT/PolD3-RIR complex determined by NMR spectroscopy 
revealed a structural basis for the relatively high affinity of this interaction. The unexpected 
discovery of PolD3-RIR motif suggests a mechanism of 'inserter' to 'extender' DNA polymerase 
switch upon Rev1/Polζ-dependent TLS, in which the PolD3-RIR binding to the Rev1-CT (i) helps 
displace the 'inserter' Polη, Polι or Polκ from its complex with Rev1, and (ii) facilitates assembly 
of the four-subunit 'extender' Polζ through simultaneous interaction of Rev1-CT with Rev7 and 
PolD3 subunits.
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Introduction
Genomic DNA undergoes constant modification by endogenous and environmental 
genotoxic agents1. If unrepaired, resulting lesions can block DNA replication by the high-
fidelity DNA polymerases, Polδ and Polε, and trigger a cascade of events leading to cell 
death1,2. To evade this catastrophic scenario, cells use specialized translesion synthesis 
(TLS) DNA polymerases that can copy over DNA lesions encountered at the replication fork 
or fill damage-containing single-stranded DNA gaps left after replication, while leaving the 
DNA damage unrepaired3-7. In humans, the major TLS enzymes include the Y-family DNA 
polymerases Rev1, Polη, Polι and Polκ, and a B-family DNA polymerase Polζ3-7 (Figure 1).
Certain DNA lesions can be accurately and efficiently bypassed by a single TLS enzyme. 
For example, Polη can copy over one of the most common UV-induced DNA lesions, T-T 
cyclobutane pyrimidine dimers (T-T CPD), in an error-free manner8. However, the bypass of 
most types of DNA damage is performed in a two-step process of Rev1/Polζ-dependent 
TLS9,10. In the first step of this process, an 'inserter' Y-family TLS DNA polymerase 
(typically one of Polη, Polι or Polκ) incorporates a nucleotide across the lesion. In the 
second step, an 'extender' TLS polymerase (typically Polζ) extends the aberrant DNA primer 
terminus before the replicative polymerase can take over DNA synthesis. Certain TLS 
enzymes are specialized for a bypass of different types of DNA lesions8,11,12. Thus, in 
addition to the bypass of TT-CPDs by Polη8, another Y-family TLS enzyme Polκ can 
efficiently replicate over N2-dG adducts such as the N2-benzo[a]pyrene-dG (BaP-dG) 
adducts resulting from exposure to smoke11,12. Therefore, the insertion step of the Rev1/
Polζ-dependent TLS may also include selection of an appropriate Y-family enzyme for the 
bypass of a given DNA lesion. Despite recognition that the two-step Rev1/polζ-dependent 
TLS is a general mechanism for DNA lesion bypass that accounts for the majority of 
mutagenesis in eukaryotes3-7,10, the molecular mechanisms of TLS enzyme selection and 
polymerase switching events still remain elusive.
The exchange of replicative to TLS DNA polymerases at replication forks stalled by DNA 
damage is triggered by Rad6/Rad18-dependent mono-ubiquitination of the sliding clamp 
PCNA13-15, which serves as a binding platform for DNA replication and damage response 
proteins16. Like replicative DNA polymerases (Polδ, Polε), Y-family TLS enzymes (Polη, 
Polι, Polκ) bind PCNA via a consensus PCNA-interacting protein (PIP) box motif4,6,16 
(Figure 1A). Rev1 is unique among Y-family TLS enzymes since it lacks the PIP-box motif 
and instead binds PCNA via its N-terminal BRCA1 C-Terminus (BRCT) domain17,18 and/or 
Polymerase Associated Domain (PAD)19 (Figure 1A). On the other hand, unlike replicative 
DNA polymerases, all eukaryotic Y-family TLS enzymes have ubiquitin-binding motifs 
(UBM) or ubiquitin-binding motifs zinc finger (UBZ) domains20 (Figure 1A) that augment 
their interaction with ubiquitinated PCNA and facilitate the replicative to TLS DNA 
polymerase switch, presumably through an affinity driven competition21.
In humans, selection of an appropriate 'inserter' TLS polymerase and an 'inserter' to 
'extender' polymerase switch during Rev1/Polζ-dependent TLS likely involve a 
rearrangement of protein-protein interactions that are mediated by Rev13-7. Rev1 is a Y-
family DNA polymerase whose catalytic activity is limited to incorporation of dCMP 
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opposite to a G-template and bypass of certain DNA lesions such as abasic sites or G-
adducts4,22-26. However, Rev1’s major role in TLS is not as a catalytic DNA polymerase27, 
but as a scaffold that recruits other TLS enzymes to DNA lesions and mediates assembly of 
the multi-polymerase complexes acting in Rev1/polζ-dependent TLS28-32. Rev1 interactions 
with other proteins are mediated by two unique modular domains missing in other Y-family 
TLS enzymes: the N-terminal Rev1-BRCT domain that interacts with PCNA17,18 and the C-
terminal Rev1-CT domain that can simultaneously bind Rev1-interacting regions (RIR) of 
one of the 'inserter' Y-family polymerases (Polη, Polι or Polκ) and a Rev7 subunit of the 
'extender' Polζ32-39 (Figure 1A). In addition, the PAD domain of yeast Rev1 was implicated 
in binding to PCNA19, Polη40 and Rev741; these interactions, however, have not been 
confirmed in vertebrates. In spite of the increasing knowledge on the structure and 
interactions of the Rev1 modular domains, their precise roles in mediating TLS polymerase 
selection and exchange are yet to be established.
The B-family TLS polymerase, Polζ, is a master 'extender' enzyme involved in Rev1/polζ-
dependent TLS across a wide range of DNA lesions10,42,43, although the Y-family TLS 
polymerase Polκ has also demonstrated ability to extend mismatched base pairs44,45. In 
addition, it was shown that Polζ can also perform a nucleotide insertion step for some DNA 
lesions46-49. The minimal functional unit of Polζ is a complex of the catalytic Rev3 and 
accessory Rev7 subunits46 (Figure 1B). Recently, several groups have shown that a more 
efficient and processive form of Polζ includes two additional subunits, human PolD2 (p50) 
and PolD3 (p66) or their yeast homologues Pol31 and Pol32 (Figure 1B), that are also 
accessory subunits of the lagging strand replicative DNA polymerase Polδ42,50-53. Assembly 
of the four-subunit Polζ (below called Polζ4) is mediated by interaction of the PolD2 (Pol31) 
subunit with the Rev3 C-terminus, which contains a zinc finger domain and an iron-sulfur 
4Fe-4S cluster50,54. Additionally, PolD2 (Pol31) forms a stable complex with the N-terminal 
domain of PolD3 (Pol32)55. The finding that Polζ may function as a four-subunit enzyme 
has led to the suggestion that the polymerase switches upon Rev1/Polζ-dependent TLS 
involve dissociation of the Polδ catalytic PolD1 and PolD2/PolD3 subunits, with the latter 
becoming a part of Polζ442,50. Consistent with this, it was shown that DNA damage causes 
Def1-dependent degradation of the catalytic subunit of yeast Polδ56 and degradation of the 
small PolD4 (p12) subunit from human Polδ resulting in its destabilization57. On the other 
hand, it was demonstrated that yeast Polζ4 is stable in all phases of cell cycle irrespective of 
DNA damage, arguing against direct sharing of subunits between Polδ and Polζ51. It also 
remains unclear how Polζ4 assembly and subunit exchange occurs on the leading DNA 
strand replicated by Polε58 (although recent reports suggest that Polδ may play a role in 
replication of both strands59,60), as well as what molecular events lead to the insertion step 
performed by Y-family TLS enzymes that precedes primer-template extension by Polζ.
The four-subunit Polζ4 has enhanced interaction with PCNA via the PIP-box motif in the 
PolD3 (Pol32) C-terminus61,62, which can be further strengthened in the Rev1/Polζ complex 
through the PCNA-binding domains of Rev117-19 and the Rev1-UBM motifs that can bind a 
ubiquitin moiety attached to PCNA20,63. Therefore, irrespective of whether Polζ4 assembles 
directly before the extension step or is recruited as pre-assembled complex, it is likely that 
the 'extender' Polζ4 can displace the 'inserter' Polη, Polι or Polκ after the completion of 
insertion step via an affinity driven competition. In this work, we show a direct physical 
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interaction between the human Rev1-CT domain and the accessory PolD3 subunit of Polζ, 
which provides additional evidence in favor of this hypothesis. The Rev1-CT - PolD3 
interaction is mediated by a Rev1-interacting region (RIR) in the unstructured C-terminal 
part of PolD3 (residues 144-466) following the N-terminal domain (residues 1-144) that 
forms a tight complex with PolD255 (Figure 1B). This newly discovered PolD3-RIR motif 
competes for the Rev1-CT binding with similar RIR motifs found in Polη, Polι and 
Polκ32,33. Thus, in the 'extender' Rev1/Polζ4 complex, the two independent binding sites on 
the Rev1-CT (one for RIR motifs and another for Rev7) can be simultaneously occupied by 
the Rev7 and PolD3 subunits of Polζ. This finding suggests a new role for the Rev1-CT - 
PolD3 interaction in stabilization of the 'extender' Rev1/Polζ4 assembly and in facilitating 
the 'inserter' to 'extender' polymerase switch by displacing the 'inserter' Polη, Polι or Polκ 
from their complex with Rev1.
Materials and Methods
Protein sample preparation
Human Rev1 C-terminal domain (Rev1-CT; residues 1158-1251) was expressed and purified 
as described previously33. The final sample of the domain used for NMR structure 
determination of the Rev1-CT/PolD3-RIR complex contained 0.7 mM 15N/13C protein, 50 
mM sodium phosphate buffer, 100 mM NaCl, 0.5 mM EDTA, 2 mM DTT, 0.05% NaN3, 
10% D2O, pH 7.0. A custom-synthesized peptide (GenScript) including the predicted RIR 
motif from human PolD3 (PolD3-RIR; residues 231-246; KGNMMSNFFGKAAMNK) has 
low solubility at the conditions used in our NMR experiments. Therefore, the Rev1-CT/
PolD3-RIR complex was prepared by dissolving lyophilized unlabeled PolD3-RIR peptide 
directly in the 15N/13C Rev1-CT domain solution and incubating the sample at room 
temperature for several hours. The excess undissolved peptide was removed by 
centrifugation and formation of the complex was monitored by recording 1H-15N HSQC 
spectrum of the domain. The procedure was repeated until only one set of the Rev1-CT 
domain peaks corresponding to the peptide-bound form of the domain was left in the 
spectrum. Similar to the Rev1-CT/Polη-RIR interaction33, the Rev1-CT/PolD3-RIR binding 
is slow on the NMR time scale, so that two sets of peaks were visible corresponding to free 
and bound forms until the protein is fully saturated with peptide.
NMR resonance assignment and structure calculation of the complex
All NMR spectra were collected at 15 ºC on Agilent VNMRS spectrometers operating at 
11.7 and 18.8 T magnetic fields equipped with cold probes; spectra were processed in 
NMRPipe64 and analyzed in CARA65. 15N, 13C and 1H NMR resonance assignments for 
the 15N/13C Rev1-CT domain in complex with the unlabeled PolD3-RIR peptide were 
obtained from two-dimensional 1H-15N HSQC and 1H-13C HSQC and three-dimensional 
HNCO, HNCACB, HBHA(CO)HN, HC(C)H-TOCSY and (H)CCH-TOCSY spectra66. 1H 
resonance assignments for the unlabeled PolD3-RIR peptide bound to the Rev1-CT domain 
were derived from two-dimensional 15N,13C-filtered TOCSY and NOESY (250 ms mixing 
time) spectra67. Spatial structure calculation for the complex was based on 1H-1H distance 
restraints derived from three types of NOESY spectra : (i) intramolecular distance restraints 
for the Rev1-CT domain were obtained from three-dimensional 15N- and 13C-edited 
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NOESY-HSQC spectra66, (ii) intermolecular protein-peptide distance restraints were 
obtained from three-dimensional 13C- and 15N-edited 15N,13C-filtered NOESY-HSQC 
spectra67 (see Supplementary Figure S3), and (iii) intramolecular distance restraints for the 
PolD3-RIR peptide were obtained from a two-dimensional 15N,13C-filtered NOESY 
spectrum67.
The structure of the Rev1-CT/PolD3-RIR complex was calculated in CYANA68 based on (i) 
inter- and intramolecular 1H-1H distance restraints obtained from the NOESY spectra 
described above, (ii) backbone dihedral φ and ψ angle restraints derived from the 
backbone 1H, 15N, and 13C chemical shifts using the program TALOS+69, and (iii) hydrogen 
bond restraints added based on dihedral φ/ψ angle and NOE analysis. Intramolecular NOE 
correlations for the Rev1-CT domain were automatically assigned using CYANA68, while 
intermolecular protein-peptide and intra-peptide NOE correlations were assigned manually. 
A total of 200 structures of the Rev1-CT/PolD3-RIR complex were generated; the 20 
lowest-energy structures were subsequently refined by constrained molecular dynamic 
simulations in explicit solvent in the software CNS70. NMR-based restraints used for the 
Rev1-CT/PolD3-RIR structure calculation and structure refinement statistics are 
summarized in Table 1.
SPR binding assays
Surface plasmon resonance (SPR) interaction assays were performed on a Biacore T100 
instrument (GE Healthcare). PolD3-RIR (residues 231-246; CKGNMMSNFFGKAAMNK) 
and Polκ-RIR (residues 560-575; CEMSHKKSFFDKKRSER) peptides modified with the 
N-terminal cysteine residue were immobilized on CM5 chips using a thiol coupling kit. All 
SPR experiments were performed in 10 mM HEPES pH 7.4, 150 mM NaCl, 0.005% (v/v) 
surfactant P20 buffer at 25 °C. Varying concentrations of the Rev1-CT domain, expressed 
and purified as described previously33, were injected over the chip surface for 300 to 500 s 
at a flow rate of 20 µL/min, followed by dissociation of the complex. Blank buffer injections 
were performed every 2 to 3 cycles during the concentration series and were used to monitor 
the stability of the experiment. Analyte responses were corrected for signals resulting from 
blank buffer injections both on a reference channel with no peptide immobilized and on 
channels with immobilized peptides. Dissociation constants (Kd) for the Rev1-CT/PolD3-
RIR and Rev1-CT/Polκ-RIR complexes were determined by equilibrium analysis of SPR 
sensorgrams using the Biacore T200 evaluation software (v.2.0).
Results
PolD3 subunit of human DNA polymerases δ and ζ contains a Rev1 interacting region
In vertebrates, the Rev1-CT domain has independent binding sites for (i) the RIR motifs of 
the 'inserter' Y-family TLS DNA polymerases Polη, Polι and Polκ and (ii) the accessory 
Rev7 subunit of the 'extender' B-family TLS polymerase Polζ32-39. The consensus RIR 
motif, which can be defined as 'nFFhhhh'32,33, consists of two consecutive phenylalanine 
residues preceded by an N-cap residue ('n': N, D, S, T, C or P)71,72 and followed by at least 
four residues that can form an α-helix ('h': all residues but P) (Figure 2A); lysine residue in 
the position +4 from the first phenylalanine is optional (found in 3 of 6 motifs shown in 
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Figure 2A). Initially, RIR motifs were found in vertebrate Y-family TLS DNA polymerases 
only and were proposed to facilitate Rev1-mediated selection of the most appropriate 
'inserter' polymerase to bypass a given type of DNA lesion32. Recent discovery of the RIR 
motif in XRCC1, a protein involved in single-strand break and base excision repair (Figure 
2A), suggests a broader role for Rev1-CT mediated interactions in regulating cross-talk of 
TLS and other DNA damage response pathways73; the Rev1 - XRCC1 interaction may also 
help recruit DNA polymerase Polβ that can bypass some lesions74,75.
The Rev1-CT domain in all eukaryotes interacts with Polζ via its accessory Rev7 subunit4. 
Electron microscopy reconstruction revealed that the four subunits of yeast Polζ4 (Rev3/
Rev7/Pol31/Pol32) are well organized relative to each other, with Pol32 (analogue of human 
PolD3) located in close proximity to Rev776. The distinct spatial arrangement of yeast Polζ4 
in this reconstruction is consistent with Polζ4 assembly stabilized by a number of 
intersubunit interactions, including those between Rev3 and Rev7, between Pol31 (analogue 
of human PolD2) and Rev3 C-terminus, and between Pol31 (PolD2) and the N-terminal 
domain of Pol32 (PolD3)55. In addition, spatial proximity of the Rev7 and Pol32 subunits 
has led to identification of a direct interaction between yeast Rev7 and the unstructured C-
terminal part of Pol32, which has been demonstrated by pull-down assay with purified 
proteins76.
Interestingly, the electron microscopy-derived model of yeast Polζ4 suggests that, in the 
context of four-subunit assembly, the Rev7 subunit is accessible for interaction with the 
Rev1-CT domain76. This implies that, in the Rev1/Polζ4 complex, the Rev1-CT domain 
likely associates with Rev7 and is located in the proximity to Pol32 (homologue of human 
PolD3). Therefore, keeping in mind that human Rev1-CT has independent binding sites for 
Rev7 and RIR motifs33-39, we have examined the primary sequence of the unstructured C-
terminal part of human PolD3 and identified a RIR motif centered at residues F238 - F239 
(Figure 2A). The discovery of a RIR motif in human PolD3 brings up the intriguing 
possibility that the two independent binding sites on Rev1-CT can be simultaneously 
occupied by two distinct subunits of Polζ4, Rev7 and PolD3. This suggests a new role for 
Rev1-CT in stabilization of Polζ4 assembly and implies a possible mechanism of 'inserter' to 
'extender' TLS polymerase switch (see below).
Rev1-CT/PolD3 binding is among the strongest interactions mediated by RIR-motifs
To confirm the Rev1-CT/PolD3-RIR interaction experimentally, we studied the formation of 
their complex by NMR spectroscopy. Figure 2B shows a comparison of 1H-15N HSQC 
spectra of the free 15N-labeled Rev1-CT domain (blue) and its complex with a 16 amino 
acid peptide corresponding to PolD3 residues 231-246 encompassing the PolD3-RIR motif 
(magenta). A number of peaks in the Rev1-CT domain have shifted to new positions after 
mixing the domain with the peptide (see Materials and Methods) consistent with specific 
binding. The pattern of chemical shift changes for the Rev1-CT domain bound to PolD3-
RIR is similar to that we previously reported for the Rev1-CT/Polη-RIR complex 
formation33, suggesting that the two RIR motifs interact with the domain in a similar 
configuration.
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In order to verify the Rev1-CT/PolD3-RIR interaction by another method and determine 
dissociation constant Kd for the complex, we have also monitored complex formation using 
a surface plasmon resonance (SPR) binding assay. In this assay, PolD3-RIR peptide 
(residues 231-246) modified with an N-terminal cysteine residue was immobilized on a 
sensor chip surface using thiol coupling chemistry, followed by monitoring complex 
formation and dissociation after injection of various concentrations of the Rev1-CT domain. 
To enable a comparison with previously published results32,73, we also performed the SPR 
assay to probe the Rev1-CT domain binding to the peptide that includes the RIR-motif from 
TLS polymerase Polκ (residues 560-575). Figures 2C and 2D, respectively, show SPR 
sensorgrams for the Rev1-CT domain interaction with the immobilized PolD3-RIR and 
Polκ-RIR peptides, and best fits of the steady state response values to a two-state binding 
model. The data analysis resulted in dissociation constants Kd of 2.3±0.6 µM for the Rev1-
CT/PolD3-RIR and 1.7±0.6 µM Rev1-CT/Polκ-RIR complexes indicative of medium 
affinity binding.
The Kd value of 7.6 µM for the Rev1-CT/Polκ-RIR complex has been previously reported 
by Ohashi et al.32 based on an SPR assay similar to that used in our work. Another group73 
reported a much stronger affinity for the Rev1-CT/Polκ-RIR complex of about 0.3 µM based 
on (i) binding assays that used changes in intrinsic tryptophan fluorescence of the Rev1-CT 
domain upon its titration with RIR peptides, and (ii) an NMR binding assay that monitored 
changes in peak intensities in 19F NMR spectrum of the 4-fluorophenylalanine-labeled Polκ-
RIR peptide upon its titration into the Rev1-CT solution. In spite of significant differences in 
the reported absolute affinities determined using different methods, the two previous 
studies32,73 were consistent in concluding that the Polκ-RIR motif binds the Rev1-CT 
domain about an order of magnitude stronger than RIR motifs from Polη, Polι or XRCC1. 
Our SPR binding data, on the other hand, suggest that PolD3-RIR affinity for Rev1-CT (2.3 
µM; Figure 2C) is about as high as that of Polκ-RIR (1.7 µM; Figure 2D), which is the 
tightest among RIR motifs.
In addition to showing the Rev1-CT/PolD3-RIR binding by NMR and SPR, we also used 
yeast two-hybrid assays in an attempt to investigate the Rev1-CT domain interaction with 
longer constructs encoding the C-terminal part of PolD3, as we had previously done when 
characterizing the Rev1-CT/Polη interaction33 (see Supplementary Materials). In contrast to 
what has been reported for Polη, Polι and Polκ32,33,36, the yeast two-hybrid assays were 
unable to detect the interaction between the Rev1-CT domain and any of the considered 
PolD3 fragments, possibly due to low expression level or low stability/solubility of the 
PolD3 constructs used for these assays. In this respect, we note that the PolD3-RIR peptide 
used for our NMR and SPR experiments is significantly more hydrophobic and less soluble 
than the corresponding RIR-peptides from Polη, Polι and Polκ (Figure 2A), and that the RIR 
motif centered at F238 - F239 is located in a relatively hydrophobic region of the PolD3 C-
terminus.
Structure of the Rev1-CT/PolD3-RIR complex
To characterize the Rev1-CT/PolD3 interaction in more detail, we have determined the 
three-dimensional structure of the Rev1-CT domain in complex with a 16 amino acid 
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synthesized peptide containing the PolD3-RIR motif (residues 231-246) by NMR 
spectroscopy. Figure 3A shows the ensemble of 20 lowest energy structures of the complex. 
The generated ensemble agrees well with the input experimental data and displays the 
backbone root-mean-square deviation (RMSD) of 0.68 Å for regular secondary structure 
elements of the Rev1-CT domain and 1.63 Å for the PolD3 fragment 235-243 that directly 
interacts with the domain (Table 1).
The structure of human Rev1-CT/PolD3-RIR complex includes key elements that are similar 
to previously reported structures of the Rev1-CT complexes with RIR motifs from Polη and 
Polκ33,36,39. The Rev1-CT domain forms a 4-helix bundle with α-helices spanning residues 
1165-1178 (H1), 1184-1199 (H2), 1203-1219 (H3) and 1224-1243 (H4) (Figure 3A,B). The 
N-terminal β-hairpin (βHP) stabilized by the two backbone hydrogen bonds between L1159 
and A1162 (NH1159-CO1162, CO1159-NH1162) docks against helices H1 and H2 and creates 
a hydrophobic patch on the domain surface with two binding pockets that can accommodate 
the sequential F238 and F239 of the PolD3-RIR motif (Figure 3C). The first hydrophobic 
pocket is formed by side-chains of L1159 from βHP, L1171, L1172, W1175 from H1 and 
D1186, Q1189, V1190 from H2 of the Rev1-CT domain and is deep enough to allow full 
insertion of the aromatic ring of F239 from the PolD3-RIR motif. The side chain of F238 
from the PolD3-RIR fits into a shallower pocket where it interacts with E1174, W1175 and 
I1179 from helix H1 of the Rev1-CT domain. Similar to what has been described for the 
Rev1-CT/Polη-RIR complex33, the negatively charged side-chain of D1186 of the Rev1-CT 
points towards the peptide backbone and interacts with HN of F238 and F239 via a charge-
dipole interaction (Figure 3C). Notably, the hydrophobic patch on the Rev1-CT surface that 
mediates its interaction with the PolD3-RIR includes three extra residues: A1160 and G1161 
from the βHP that interact with A242, A243 and M244 from the C-terminal part of the 
PolD3-RIR peptide, and M1183 from the H1-H2 loop that interacts with M234 - N237 N-
terminal to the FF pair of the RIR motif (Figure 3C). In addition, the negatively charged 
E1185 from helix H2 interacts with the backbone HN of N233 from the N-terminal part of 
the PolD3-RIR peptide (Figure 3C).
Figure 3B shows a superposition of the Rev1-CT/PolD3-RIR structure reported in this work 
(magenta) and the structures of Rev1-CT complexes with RIR motifs from Polη (blue; PDB 
ID: 2LSK)33 and Polκ (green; PDB ID: 2LSI)39. Overall, the mode of RIR motif interaction 
with the Rev1-CT domain is conserved among all complexes whose structures are available 
in the Protein Data Bank (PDB). In all structures, (i) aromatic side-chains of the two 
sequential phenylalanine residues of RIR motifs interact with pre-formed binding pocket on 
the domain surface, and (ii) the FF pair and the following several residues of RIR motifs are 
found in α-helical conformation. In all cases, the Rev1-CT - RIR complex is stabilized by 
polar interactions between the backbone amides of the two phenylalanine residues of the 
RIR motif and Oδ of D1186 of the Rev1-CT domain. However, in contrast to the RIR motifs 
from Polη and Polκ that upon binding form 2 to 3 turns of an α-helix33,36,39, only 3 residues 
of the PolD3-RIR motif bound to Rev1-CT were found in an α-helical conformation (Figure 
3). A possible reason is the presence of G240 immediately following the FF pair, which has 
the second lowest (after P) propensity to form an α-helix among amino acids77. This 
configuration of the PolD3-RIR peptide, however, is sufficient to maintain the correct 
orientation of the sequential F238 and F239 towards the domain surface. Interestingly, a 
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relatively short α-helix has been also reported for the XRCC1-RIR motif bound to the Rev1-
CT domain73. On the other hand, the structure of the Rev1-CT domain does not undergo 
significant changes upon binding different RIR motifs. Mean pairwise RMSD for the Rev1-
CT domain bound to RIR motifs from Polη (2LSK)33, Polκ (2LSI)39 and PolD3 (this work) 
is 1.1 Å for the backbone and 2.1 Å for all heavy atoms (calculated for residues from 
regularly structure elements), while RMSD between the free (2LSY)33 and PolD3-bound 
Rev1-CT is 1.4 Å for the backbone and 2.3 Å for all heavy atoms.
The lack of an extended α-helix in the bound form of the PolD3-RIR peptide poses a 
question of why the Rev1-CT/PolD3-RIR interaction is among the strongest mediated by 
RIR motifs. In the Rev1-CT complexes with RIR motifs from Polη and Polκ33,36,39, most 
intermolecular contacts are mediated by the six residues on the side of the RIR α-helix 
facing the domain (underlined in 'nFFhhhh', where 'n' is the N-cap residue, and 'h' is a helix-
forming residue). In contrast, the PolD3-RIR motif adopts a more extended conformation 
with several additional residues involved in direct interaction with the Rev1-CT domain. 
Thus, protein-peptide NOEs were observed for the PolD3 fragment spanning residues 
233-244, resulting in 83 intermolecular distance restraints that were used for structure 
calculation of the Rev1-CT/PolD3- RIR complex (Table 1). This number is greater than the 
number of protein-peptide distance restraints previously used for NMR structure calculation 
of the Rev1-CT/Polη-RIR complex, in which the RIR motif forms a 9-residue α-helix33. In 
the Rev1-CT/PolD3-RIR complex, intermolecular NOEs were observed for the four residues 
N-terminal to the FF pair (N233, M235, S236 and N237), which interact with the H1-H2 
loop and the beginning of α-helix H2 (Figure 3C). Furthermore, intermolecular NOEs were 
observed for G240, A242, A243 and M244 (following the FF pair) that form an extended tail 
in the PolD3-RIR, which interacts with the tip of the Rev1-CT N-terminal β-hairpin formed 
by A1160 and G1161 (Figure 3C). While opposing the PolD3-RIR α-helix formation, 
interactions mediated by the above PolD3 residues contribute to an extensive Rev1-CT/
PolD3-RIR interface, likely resulting in additional stabilization of the complex.
Discussion
Regulation of translesion synthesis (TLS) in eukaryotes occurs on multiple levels, including 
transcriptional control of protein expression, protein degradation, protein post-translational 
modifications and, most importantly, protein interactions3-7. The access of TLS enzymes to 
DNA, assembly of multi-polymerase complexes and polymerase switching events are 
regulated via a range of protein-protein and protein-DNA interactions mediated by 
interaction motifs, modular domains and subunits of TLS DNA polymerases3-7 (Figure 1). 
Some of these interactions are fairly tight, while many others such as Rev1-CT interactions 
with RIR motifs from human Polη, Polι, Polκ and PolD3 are weaker (µM to mM affinities) 
and are often competitive with one another32,33,36,39. One can expect that, owing to these 
relatively weak and competitive interactions, the TLS assembly is configured differently at 
each step of DNA lesion bypass, at different types of lesions and at replication forks vs. 
postreplication gaps, with only a subset of possible interactions formed at a given time.
In this work, we discovered a previously unknown RIR motif in the unstructured C-terminal 
part of PolD3 subunit of human Polδ and Polζ (Figure 2A). We studied the Rev1-CT - 
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PolD3-RIR interaction by NMR and SPR, and demonstrated that the Rev1-CT/PolD3-RIR 
and Rev1-CT/Polκ-RIR complexes are among the tightest mediated by RIR motifs 
(dissociation constants Kd of 2.3±0.6 and 1.7±0.6 µM, respectively; Figures 2B-D). 
Furthermore, we used NMR spectroscopy to determine the three-dimensional structure of 
the Rev1-CT/PolD3-RIR complex, revealing a structural basis for the relatively high affinity 
of this interaction (Figure 3). The unexpected finding of a RIR motif in the PolD3 subunit of 
Polζ that can bind the Rev1-CT domain suggests a new role for Rev1-CT in stabilization of 
the four-subunit Polζ4 and offers potential new insights into the mechanism of 'inserter' to 
'extender' polymerase switch upon mutagenic Rev1/Polζ-dependent TLS. This finding fits 
well into a model of reorganization of a multi-polymerase complex upon Rev1/Polζ-
dependent TLS discussed below, in which the assembly of the 'extender' four-subunit Polζ4 
results in Polζ acquiring Rev1 and PCNA interacting motifs found in the PolD3 subunit 
(Figure 1) that help Polζ displace an 'inserter' enzyme (one of Polη, Polι and Polκ) via an 
affinity driven competition.
Figure 4 illustrates a possible model of reorganization of protein-protein interactions in a 
multi-polymerase complex that carries out two-step Rev1/Polζ-dependent TLS. Following 
DNA damage, the Rad6/Rad18 hetero-dimer is recruited to stretches of single-stranded DNA 
formed at stalled replication forks78 and mono-ubiquitinates the sliding clamp PCNA13-15. 
This event signals switching from normal DNA replication to the insertion step of TLS 
performed by Y-family DNA polymerases Polη, Polι or Polκ13-15 (Figures 4A); Rev14,22-26 
and Polζ46-49 can also insert opposite particular lesions. Y-family TLS enzymes can interact 
with ubiquitinated PCNA via their PCNA-binding domains (PIP-box motifs in Polη, Polι, 
Polκ or BRCT domain in Rev1) and ubiquitin-binding UBM (Rev1, Polι) or UBZ (Polη, 
Polκ) domains that are not present in replicative DNA polymerases (Polδ, Polε)20. 
Ubiquitin-binding domains strengthen interactions of TLS enzymes with PCNA and mediate 
the replicative to TLS DNA polymerase switch, which presumably occurs via affinity-driven 
competition21. Additionally, the replicative to TLS DNA polymerase switch may involve 
destabilization and disassembly of the multi-subunit replicative polymerase Polδ56,57, 
resulting in release of a complex of its accessory PolD2/PolD3 subunits.
The formation of Polη foci and one-polymerase bypass of the Polη cognate lesion, UV-
induced TT-CPD, depends on Polη interactions with PCNA and ubiquitin mediated by PIP-
box and UBZ domains20,21, but not on the Polη interaction with Rev1 mediated by a RIR 
motif79. Thus, a Polη variant with F to A mutations in both RIR motifs (see Figure 2A) was 
able to suppress UV-induced mutagenesis and complement UV sensitivity of XPV cells to a 
similar extent as the wild-type Polη, suggesting that the Polη mutant effectively promotes 
single-polymerase bypass of the UV-induced TT-CPDs80. On the other hand, this Polη 
variant resulted in increased rate of spontaneous mutations as compared to wild-type Polη, 
consistent with a model where the Polη-RIR - Rev1 interaction is required for TLS across 
other types of DNA damage that Polη alone is unable to efficiently bypass80. A Polκ variant 
with F to A mutations in its RIR motif, which is defective in Rev1 binding, was unable to 
complement Polκ−/− mouse embryonic fibroblasts after exposure to benzo[a]pyrene in a 
DNA damage sensitivity assay, showing that the Polκ-RIR - Rev1 interaction is required for 
the bypass of the Polκ cognate DNA lesion BaP-dG32. Taken together, these findings 
suggest that if one Y-family TLS enzyme cannot efficiently copy over a DNA lesion, the 
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Rev1-CT interactions with RIR motifs from this and other TLS enzymes facilitate selection 
of a more appropriate TLS DNA polymerase capable of completing the task. For example, if 
Polη is not proficient in incorporating a nucleotide across a DNA lesion, it may be replaced 
by another TLS enzyme such as Polκ whose RIR motif binds the Rev1-CT domain an order 
of magnitude stronger than RIR motifs from Polη32,73.
Previous studies of the Rev1-CT domain interactions with RIR motifs from Polη, Polι and 
Polκ did not address whether the Rev1-CT - RIR binding is only required for the selection of 
an appropriate 'inserter' TLS enzyme, or whether it also plays a role in the 'inserter' to 
'extender' polymerase switch. The 'extender' Polζ is recruited to replication foci by Rev1 
presumably through the Rev1-CT - Rev7 interaction79. The discovery of RIR motif in the C-
terminal part of the PolD3 subunit of Polζ reported in this work suggests a possible key role 
for the Rev1-CT - PolD3-RIR interaction in facilitating the 'inserter' (Polη, Polι or Polκ) to 
'extender' (Polζ) TLS polymerase switch (Figures 4). First, PolD3-RIR competes with RIR 
motifs from Y-family 'inserter' TLS enzymes for Rev1-CT binding and thus can help 
displace an 'inserter' enzyme from its complex with Rev1, weakening the 'inserter' enzyme 
interaction with the TLS complex assembled on mono-ubiquitinated PCNA. Second, the 
Rev1-CT - PolD3-RIR interaction can facilitate the assembly of 'extender' Polζ4 (Rev3/
Rev7/PolD2/PolD3 complex)50,53. In the Rev1/Polζ4 complex, the two independent binding 
sites on the Rev1-CT domain34-39 can simultaneously interact with the Rev7 and PolD3 
subunits of Polζ (Figure 4B). These interactions may play a role in stabilizing the Polζ4 
complex in addition to interactions between the Rev7-binding motif of Rev3 (Rev7BD) and 
Rev781, between the Rev3 C-terminal domain (CTD) and PolD250,54, between PolD2 and 
the N-terminal domain of PolD355 and, possibly, between the PolD3 C-terminus and Rev7 
(as shown in yeast76) (Figure 4B). The resulting 'extender' Rev1/Polζ4 complex would have 
an enhanced interaction with mono-ubiquitinated PCNA mediated by the Rev1-UBM20,63, 
Rev1-BRCT17,18 and presumably Rev1-PAD19 domains as well as by a PIP-box motif in the 
PolD3 C-terminus61,62. On the other hand, the 'inserter' Y-family TLS enzyme, which no 
longer interacts with Rev1, would have a decreased interaction with the TLS complex 
assembled on mono-ubiquitinated PCNA, and can be displaced from the DNA primer-
template by an affinity driven competition (Figure 4B).
Interestingly, the only 'inserter' Y-family TLS polymerase in S. cerevisiae yeast, Polη, lacks 
a RIR motif and arguably interacts with the Rev1-PAD, but not with the Rev1-CT domain40. 
Consistent with this, inspection of the primary sequence of Pol32 subunit of yeast Polζ 
(homologue of human PolD3) did not reveal obvious candidate RIR motifs capable of Rev1-
CT binding except 338-QGTLESFFKRKAK-350 at the very C-terminus, which serves as 
PCNA-interacting PIP-box motif. In addition, Rev1-CT – Pol32 binding was not detected in 
pull-down assays with purified proteins82. These data may suggest that regulation of TLS 
polymerase selection and exchange via the Rev1-CT – RIR motif interaction is a mechanism 
evolved in higher eukaryotes together with the emergence of additional Y-family TLS DNA 
polymerases, Polι and Polκ. Furthermore, higher eukaryotes acquired additional levels of 
TLS control such as negative regulation of Rev1/Polζ-dependent TLS by a putative human 
metalloprotease Spartan83, which is not found in yeast42. Remarkably, the primary sequence 
of human Spartan also contains a previously unnoticed RIR motif centered at F420 - F421 
(whose interaction with Rev1-CT has been confirmed by 15N NMR; Supplementary Figure 
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S2) that might help explain why Spartan depletion promotes complex formation between 
Rev1 and the PolD3 subunit of Polζ83. One should note, however, that the N-terminal part of 
human Rev1-CT responsible for interaction with RIR motifs exhibits higher sequence 
conservation between human and yeast than the C-terminal part that binds the Rev7 subunit 
of Polζ84, the interaction conserved between human and yeast4. Therefore, one cannot 
exclude a possibility that the yeast Rev1-CT domain might weakly interact with a RIR 
sequence somewhat different from that described in higher eukaryotes (e.g. 214-
NLFVEDD-220 or 290-SFIDEDG-296 found in the C-terminal part of yeast Pol32 where 
the two residues with bulky hydrophobic side-chains follow an N-capping residue).
In summary, we have described interaction between the Rev1-CT domain and a newly 
discovered RIR motif from the C-terminal part of the PolD3 subunit of human Polδ and 
Polζ. The structure of the Rev1-CT/PolD3-RIR complex shows that PolD3-RIR binds Rev1-
CT in a manner similar to RIR motifs from Polη and Polκ33,36,39, with the two sequential 
phenylalanine residues of the RIR motif mediating critical intermolecular contacts (Figure 
3). However, in contrast to RIR motifs from Polη and Polκ, which upon binding form 
extended α-helices, in the Rev1-CT/PolD3-RIR complex only three residues of the PolD3-
RIR were found in α-helical conformation. And yet, because of extensive contacts between 
Rev1-CT and RIR residues preceding and following FF pair, the Rev1-CT - PolD3-RIR 
interaction is among the strongest mediated by RIR motifs (Figures 2,3). The unexpected 
finding of RIR motif in the PolD3 subunit of Polδ and Polζ suggests a new role for Rev1-CT 
in stabilization of the functional four-subunit Polζ4 (Rev3/Rev7/PolD2/PolD3 complex)4, in 
which the Rev1-CT domain can simultaneously bind Rev7 and PolD3 subunits. 
Furthermore, this finding, along with previously published interaction data, provides new 
insights into the mechanism of 'inserter' (Polη, Polι, Polκ) and 'extender' (Polζ) polymerase 
switch upon mutagenic Rev1/Polζ-dependent TLS. In the proposed model of polymerase 
exchange (Figure 4), the relatively high affinity binding of PolD3-RIR to Rev1-CT helps 
displace the 'inserter' Polη, Polι or Polκ from its complex with Rev1 and promotes the 
formation the 'extender' Rev1/Polζ4 assembly, thus modulating affinities of 'inserter' and 
'extender' complexes to mono-ubiquitinated PCNA.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
A. Structural domains of human Y-family TLS DNA polymerases Rev1, Polη, Polι, Polκ3-7. 
The core polymerase domain consists of the palm, finger and thumb domains, and a 
polymerase associated domain (PAD) unique to Y-family TLS enzymes. In addition, Y-
family TLS polymerases possess accessory domains and motifs that mediate a range of 
protein-protein interactions. B. Subunits of human B-family TLS DNA polymerase Polζ and 
their domain arrangement42 (see text for details).
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Figure 2. 
A. Primary sequence alignment of the Rev1-interacting regions (RIR) from human PolD3 
subunit of Polδ and Polζ, Y-family TLS DNA polymerases Polη, Polι and Polκ, and a single-
strand break and base excision repair protein, XRCC173. B. Overlay of 1H-15N HSQC 
spectra of the free 15N/13C Rev1-CT domain (blue) and its complex with the unlabeled 
PolD3 RIR-motif (magenta). B, C. Surface plasmon resonance (SPR) sensorgrams for the 
Rev1-CT domain injected over the PolD3-RIR (plot C) and Polκ-RIR (plot D) peptides 
immobilized on a sensor chip surface (top panels) and best fits of the steady state response 
values to a two-state binding model (bottom panels).
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Figure 3. 
A. Superposition of 20 lowest-energy structures of the human Rev1-CT/PolD3-RIR 
complex. The Rev1-CT domain α-helices are shown in different colors; PolD3 peptide 
(residues 231-246) is shown in magenta with F238 and F239 side-chains highlighted. B. 
Comparison of known structures of the human Rev1-CT domain in complexes with RIR 
motifs from different partners: Polκ-RIR (green; PDB# 2LSI), Polη-RIR (blue; PDB# 
2LSK) and PolD3-RIR (magenta; PDB# 2N1G, this work). B. Close up view of the PolD3-
RIR interaction with the Rev1-CT domain surface. Side-chains of key residues of the Rev1-
CT domain and PolD3-RIR motif that mediate intermolecular interactions are labeled in 
blue and magenta, respectively.
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Figure 4. 
A model or reorganization of protein-protein interactions and 'inserter' to 'extender' DNA 
polymerase switch upon a two-step Rev1/Polζ-dependent TLS. A. A possible configuration 
of the multi-polymerase TLS complex, including TLS DNA polymerases Rev1, and Polη 
(Polι, Polκ) and Polζ, assembled on mono-ubiquitinated PCNA at the nucleotide 'insertion' 
step of Rev1/Polζ-dependent TLS. In this configuration, a catalytic domain of the 'inserter' 
Y-family TLS polymerase Polη has access to DNA. Polη interactions with mono-
ubiquitinated PCNA are mediated by Polη-UBZ domain and Polη-PIP motif. Rev1 binding 
to mono-ubiquitinated PCNA is mediated by Rev1-BRCT, Rev1-PAD, Rev1-UBM domains 
and to Polη-RIR by the Rev1-CT domain. In addition, the Rev1-CT domain mediates 
recruitment of Polζ through interaction with its Rev7 subunit. Presumably, Polη is recruited 
to stalled replication forks independently of other TLS enzymes via interaction with Rad18, 
which mono-ubiquitinates PCNA85. Rev1 is reportedly recruited to replication foci 
independently of Polη31,79, while Polζ is recruited via interaction with Rev179 either as two- 
or four-subunit (Polζ4) complex. In case Polη fails to insert a nucleotide across DNA lesion, 
a more appropriate 'inserter' Y-family enzyme (Polι, Polκ) may take over Polη by interacting 
with mono-ubiquitinated PCNA via its UBM/UBZ/PIP-box and trading its RIR motif with 
Polη-RIR bound to the Rev1-CT. B. A possible configuration of the multi-polymerase TLS 
complex at the primer-templete 'extension' step of Rev1/Polζ-dependent TLS. In this 
configuration, a catalytic domain of the 'extender' B-family polymerase Polζ has access to 
DNA. The 'extender' Polζ4 may take over the 'inserter' Polη (Polι or Polκ) by displacing 
Polη-RIR motif bound to the Rev1-CT with the PolD3-RIR and, in this way, disrupting 
Polη/Rev1 interaction. The Rev1-CT domain interactions with Rev7 and PolD3 subunits of 
Polζ stabilize the 'extender' Rev1/Polζ4 assembly that can interact with ubiquitinated PCNA 
via Rev1-BRCT, Rev1-PAD, Rev1-UBM domains and PolD3-PIP motif.
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Table 1
NMR-based restraints used for structure calculation of the Rev1-CT domain complex with the PolD3-RIR 
peptide (residues 231-246).
Total Rev1-CT PolD3
Summary of restraints
Total NOE distance restraints 2580 2411 86
 Short range (|i-j|≤1) 1074 989 85
 Medium range (1<|i-j|≤4) 861 860 1
 Long range (|i-j|>4) 562 562
 Intermolecular 83
Dihedral angles restraints (φ/ ψ) 85/80 78/78 7/2
Hydrogen bonds 57 57
Structure refinement statistics
Deviation from NMR-based restraints
NOE (Å) 1.04
Dihedral restraints (degrees) 0.82
Deviation from idealized geometry
Bonds (Å) 0.02
Angles (degrees) 1.3
Ramachandran plot favorable for selected residues a 97.5%
RMSD, pairwise (Å)
All residues
Backbone atoms 0.94±0.16
Heavy atoms 1.56±0.16
Residues from regular secondary structure elements a
Backbone atoms 0.68±0.14 1.63±0.51
Heavy atoms 1.38±0.15 2.80±0.79
a
- Residues 1165-1178, 1184-1199, 1203-1219, 1224-1243 of the Rev1-CT domain and residues 235-243 of the PolD3-RIR peptide involved in 
interaction with the domain.
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